Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.57 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.57 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.50 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.50 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | FDPS | P14324 | 3/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1869680 | 1.00 | GPR84 (0.59) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL533870 | 1.00 | GPR84 (0.59) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL28577980 | 1.00 | GPR84 (0.59) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL29090021 | 1.00 | GPR84 (0.59) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL1875853 | 0.97 | — | — | |
| Benzene SCHEMBL28050653 | 0.93 | GPR84 (0.59) | GPR84FFAR1FFAR4PSMD14PLA2G1B | |
| SCHEMBL1873762 | 0.90 | — | — | |
| SCHEMBL2381697 | 0.90 | — | — | |
| SCHEMBL2381278 | 0.90 | — | — | |
| SCHEMBL23789287 | 0.84 | FFAR1 (0.67) | GPR84FFAR1FFAR4PSMD14PLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117510500-A | Preparation method of asperazepanones alkaloid and application of asperazepanones alkaloid as anti-inflammatory drug | 中国海洋大学 | 2024-02-06 | — | — | CN | disclosed |
| CN-117050043-A | 3-phenyl dibenzofuran compound and preparation method and application thereof | 中国海洋大学 | 2023-11-14 | — | — | CN | disclosed |
| CN-116726010-A | Application of macrolide derivative in preparation of medicines for inhibiting pro-inflammatory cytokine acting agents | 中国海洋大学 | 2023-09-12 | — | — | CN | disclosed |
| CN-112851622-B | Macrolide brefeldin A ester derivative and application thereof | 中国海洋大学 | 2023-01-10 | — | — | CN | disclosed |
| CN-112851622-A | Macrolide brefeldin A ester derivative and application thereof | 中国海洋大学 | 2021-05-28 | — | — | CN | disclosed |
| US-10793589-B2 | Resorcinarene-based amphipathic compound and use thereof | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2020-10-06 | — | — | US | disclosed |
| US-20200102341-A1 | NEW RESORCINARENE-BASED AMPHIPATHIC COMPOUND AND USE THEREOF | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2020-04-02 | — | — | US | disclosed |
| CN-1088199-A | The aniline that N-replaces | HOFFMANN LA ROCHE (CH) | 1994-06-22 | — | — | CN | disclosed |
| US-5001243-A | Substituted naphthacene-5, 12-diones | CIBA-GEIGY CORPORATION (US) | 1991-03-19 | — | — | US | disclosed |
| US-4295852-A | Process for dyeing polyamide fibres | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200102341-A1 | NEW RESORCINARENE-BASED AMPHIPATHIC COMPOUND AND USE THEREOF | ERP44, RFTN1, TGOLN2 | GPR84 223/4885FFAR1 1814/4885FFAR4 1223/4885 |
| US-10793589-B2 | Resorcinarene-based amphipathic compound and use thereof | ERP44, RFTN1, VMA21 | GPR84 223/4885FFAR1 1855/4885FFAR4 1192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.